Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018

Published:2021-05-07 Issue: Volume: Page:1-3
ISSN:0899-823X
Container-title:Infection Control & Hospital Epidemiology
language:en
Short-container-title:Infect. Control Hosp. Epidemiol.

Author:

Kazakova Sophia V.^ORCID,Baggs James,Yi Sarah H.,Reddy Sujan C.,Hatfield Kelly M.,Guh Alice Y.,Jernigan John A.,McDonald L. Clifford

Abstract

Abstract Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference10 articles.

1. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network

2. High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals

3. Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012

4. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network

5. 10. Fridkin, S BJ , Fagan, R , et al. Vital signs: improving antibiotic use among hospitalized patients. Morb Mortal Wkly Rep 2014;63194–200.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Environmental approaches to controlling Clostridioides difficile infection in healthcare settings;Antimicrobial Resistance & Infection Control;2023-09-07

2. Impact of the COVID-19 pandemic on the incidence of healthcare-associated Clostridioides difficile infection in a tertiary healthcare facility in the Republic of Ireland;Infection Prevention in Practice;2023-09

3. Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017–2019;Journal of Antimicrobial Chemotherapy;2023-08-01

4. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020;Emerging Infectious Diseases;2023-05

5. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin;JAC-Antimicrobial Resistance;2023-03-02